GlassScriptPhysician profile
David J Kelly
NPI 1194862417
$587.10
in general payments reported to CMS, 2019-2025
17 companies · $41.69 in 2025
The $41.69 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $62.39 · 2021: $48.48 · 2023: $16.20 · 2024: $36.92 · 2025: $41.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $94.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $94.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $87.52 | 2019-2020 | |
| Amgen INC. | $80.44 | 2019 | |
| Pfizer INC. | $79.51 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $48.07 | 2019 | |
| Glaxosmithkline, LLC. | $47.98 | 2019 | |
| Astellas Pharma US INC | $30.03 | 2019 | |
| Dexcom, INC. | $26.45 | 2025 | Dexcom G6 Transmitter |
| Nevro Corp. | $25.26 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $24.52 | 2019 | |
| Abbvie INC. | $23.22 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.20 | 2024 | |
| Horizon Therapeutics Plc | $16.86 | 2019 | |
| Ironshore Pharmaceuticals INC. | $16.47 | 2019 | |
| Supernus Pharmaceuticals, INC. | $16.20 | 2023 | Qelbree |
| Antares Pharma, INC. | $15.72 | 2024 | Xyosted |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $15.24 | 2025 | Azstarys |
| Kowa Pharmaceuticals America, INC. | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.